Only 8 Of The 30 Dow Jones Stocks Were Positive In The First Half Of 2022: Chevron Leads, But Who Else Was Up?Benzinga • 07/01/22
AMGEN FOUNDATION MORE THAN DOUBLES COMMITMENT TO LABXCHANGE, FREE VIRTUAL SCIENCE EDUCATION PLATFORMPRNewsWire • 06/20/22
Amgen Inc. (AMGN) Management Presents at Goldman Sachs 43rd Annual Global Healthcare ConferenceSeeking Alpha • 06/16/22
Amgen Inc. (AMGN) Management Presents at 2022 Jefferies Global Healthcare Conference (Transcript)Seeking Alpha • 06/08/22
Why 8 Big-Dividend Defensive Stocks Can Be Huge Winners If Market Struggles Continue24/7 Wall Street • 06/07/22
FDA APPROVES RIABNI™ (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXAN® (RITUXIMAB), FOR ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITISPRNewsWire • 06/06/22
NEW HEAD-TO-HEAD DATA SHOW VECTIBIX® (PANITUMUMAB) DEMONSTRATED SUPERIOR OVERALL SURVIVAL COMPARED TO BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN JAPANESE PATIENTS WITH WILD-TYPE RAS COLORECTAL CANCERPRNewsWire • 06/05/22
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 2 DATA FOR INVESTIGATIONAL OLPASIRAN IN ADULTS WITH ELEVATED LIPOPROTEIN(a)PRNewsWire • 05/31/22
Shareholder Alert: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amgen Inc. - AMGNNewsfile Corp • 05/28/22